

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.04495715 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.04495715 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.86790077 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.86790077 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.78262014 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 5.54574104 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 5.54574104 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.54574104 |
| 9 | lysine catabolic process (GO:0006554) | 5.46721276 |
| 10 | lysine metabolic process (GO:0006553) | 5.46721276 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.32825049 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.31090378 |
| 13 | cysteine metabolic process (GO:0006534) | 5.27420186 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.12281100 |
| 15 | serine family amino acid catabolic process (GO:0009071) | 4.92908875 |
| 16 | establishment of integrated proviral latency (GO:0075713) | 4.89457450 |
| 17 | homocysteine metabolic process (GO:0050667) | 4.81535878 |
| 18 | bile acid biosynthetic process (GO:0006699) | 4.67205306 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.66326728 |
| 20 | nuclear pore complex assembly (GO:0051292) | 4.64477024 |
| 21 | CENP-A containing nucleosome assembly (GO:0034080) | 4.60774008 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.59835097 |
| 23 | amino-acid betaine metabolic process (GO:0006577) | 4.59195585 |
| 24 | chromatin remodeling at centromere (GO:0031055) | 4.54696768 |
| 25 | urea cycle (GO:0000050) | 4.53175703 |
| 26 | urea metabolic process (GO:0019627) | 4.53175703 |
| 27 | urate metabolic process (GO:0046415) | 4.51006328 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.49685604 |
| 29 | glycine metabolic process (GO:0006544) | 4.45836267 |
| 30 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.44432813 |
| 31 | serine family amino acid metabolic process (GO:0009069) | 4.38162863 |
| 32 | purine nucleobase biosynthetic process (GO:0009113) | 4.34533587 |
| 33 | nuclear pore organization (GO:0006999) | 4.33738279 |
| 34 | IMP biosynthetic process (GO:0006188) | 4.32153541 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.30289898 |
| 36 | ribosome assembly (GO:0042255) | 4.27686576 |
| 37 | serine family amino acid biosynthetic process (GO:0009070) | 4.27345175 |
| 38 | DNA strand elongation (GO:0022616) | 4.26623135 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 4.19260656 |
| 40 | proteasome assembly (GO:0043248) | 4.17273051 |
| 41 | nitrogen cycle metabolic process (GO:0071941) | 4.16294779 |
| 42 | drug transmembrane transport (GO:0006855) | 4.15986208 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 4.15171206 |
| 44 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.14618274 |
| 45 | drug catabolic process (GO:0042737) | 4.11148111 |
| 46 | bile acid metabolic process (GO:0008206) | 4.01525566 |
| 47 | high-density lipoprotein particle remodeling (GO:0034375) | 3.99356598 |
| 48 | formation of translation preinitiation complex (GO:0001731) | 3.98418839 |
| 49 | IMP metabolic process (GO:0046040) | 3.98241875 |
| 50 | indolalkylamine metabolic process (GO:0006586) | 3.96655607 |
| 51 | 2-oxoglutarate metabolic process (GO:0006103) | 3.86430839 |
| 52 | protein localization to kinetochore (GO:0034501) | 3.86149828 |
| 53 | nucleobase biosynthetic process (GO:0046112) | 3.85402731 |
| 54 | cellular amino acid catabolic process (GO:0009063) | 3.85367192 |
| 55 | mitotic metaphase plate congression (GO:0007080) | 3.84323794 |
| 56 | negative regulation of fibrinolysis (GO:0051918) | 3.83450005 |
| 57 | histone exchange (GO:0043486) | 3.82646135 |
| 58 | regulation of triglyceride catabolic process (GO:0010896) | 3.81021256 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 3.80987640 |
| 60 | amine catabolic process (GO:0009310) | 3.80987640 |
| 61 | regulation of protein activation cascade (GO:2000257) | 3.80700899 |
| 62 | protein carboxylation (GO:0018214) | 3.79576807 |
| 63 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.79576807 |
| 64 | complement activation, alternative pathway (GO:0006957) | 3.78072256 |
| 65 | valine metabolic process (GO:0006573) | 3.77170053 |
| 66 | DNA replication-independent nucleosome organization (GO:0034724) | 3.74519250 |
| 67 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.74519250 |
| 68 | DNA replication checkpoint (GO:0000076) | 3.74026039 |
| 69 | tyrosine metabolic process (GO:0006570) | 3.73566886 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 3.72240161 |
| 71 | establishment of viral latency (GO:0019043) | 3.71861929 |
| 72 | drug transport (GO:0015893) | 3.70217272 |
| 73 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.67751970 |
| 74 | regulation of fibrinolysis (GO:0051917) | 3.67054736 |
| 75 | carnitine metabolic process (GO:0009437) | 3.65401842 |
| 76 | aspartate family amino acid catabolic process (GO:0009068) | 3.64450920 |
| 77 | cellular glucuronidation (GO:0052695) | 3.63965740 |
| 78 | fatty acid beta-oxidation (GO:0006635) | 3.63120272 |
| 79 | telomere maintenance via recombination (GO:0000722) | 3.62248590 |
| 80 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.61432707 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 3.60034266 |
| 82 | aldehyde catabolic process (GO:0046185) | 3.58924407 |
| 83 | regulation of cholesterol esterification (GO:0010872) | 3.58754629 |
| 84 | triglyceride homeostasis (GO:0070328) | 3.58483770 |
| 85 | acylglycerol homeostasis (GO:0055090) | 3.58483770 |
| 86 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.57940702 |
| 87 | mitotic recombination (GO:0006312) | 3.57447097 |
| 88 | regulation of complement activation (GO:0030449) | 3.57020855 |
| 89 | mitotic sister chromatid cohesion (GO:0007064) | 3.55883217 |
| 90 | bile acid and bile salt transport (GO:0015721) | 3.55862170 |
| 91 | exogenous drug catabolic process (GO:0042738) | 3.54285327 |
| 92 | branched-chain amino acid catabolic process (GO:0009083) | 3.54087046 |
| 93 | non-recombinational repair (GO:0000726) | 3.53661359 |
| 94 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.53661359 |
| 95 | fatty acid oxidation (GO:0019395) | 3.53615460 |
| 96 | imidazole-containing compound metabolic process (GO:0052803) | 3.52334099 |
| 97 | DNA unwinding involved in DNA replication (GO:0006268) | 3.51906946 |
| 98 | negative regulation of cholesterol transport (GO:0032375) | 3.51754364 |
| 99 | negative regulation of sterol transport (GO:0032372) | 3.51754364 |
| 100 | carboxylic acid catabolic process (GO:0046395) | 3.48902161 |
| 101 | organic acid catabolic process (GO:0016054) | 3.48902161 |
| 102 | protein localization to chromosome, centromeric region (GO:0071459) | 3.47497346 |
| 103 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.47352456 |
| 104 | negative regulation of sister chromatid segregation (GO:0033046) | 3.47352456 |
| 105 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.47352456 |
| 106 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.47352456 |
| 107 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.47352456 |
| 108 | mitotic spindle checkpoint (GO:0071174) | 3.46369222 |
| 109 | plasma lipoprotein particle remodeling (GO:0034369) | 3.45977988 |
| 110 | protein-lipid complex remodeling (GO:0034368) | 3.45977988 |
| 111 | macromolecular complex remodeling (GO:0034367) | 3.45977988 |
| 112 | lipid oxidation (GO:0034440) | 3.45844461 |
| 113 | branched-chain amino acid metabolic process (GO:0009081) | 3.45472286 |
| 114 | reverse cholesterol transport (GO:0043691) | 3.44361909 |
| 115 | negative regulation of chromosome segregation (GO:0051985) | 3.44169958 |
| 116 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.43446861 |
| 117 | cellular modified amino acid catabolic process (GO:0042219) | 3.41579479 |
| 118 | spindle checkpoint (GO:0031577) | 3.41352604 |
| 119 | ethanol oxidation (GO:0006069) | 3.40355693 |
| 120 | phospholipid efflux (GO:0033700) | 3.38650356 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 3.38181182 |
| 122 | pore complex assembly (GO:0046931) | 3.37896248 |
| 123 | mitotic sister chromatid segregation (GO:0000070) | 3.37767725 |
| 124 | L-serine metabolic process (GO:0006563) | 3.36810606 |
| 125 | metaphase plate congression (GO:0051310) | 3.36154136 |
| 126 | DNA ligation (GO:0006266) | 3.35060001 |
| 127 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.34983593 |
| 128 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.34983593 |
| 129 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.34733287 |
| 130 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.34733287 |
| 131 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.34409632 |
| 132 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.32238180 |
| 133 | negative regulation of ligase activity (GO:0051352) | 3.32238180 |
| 134 | acetyl-CoA metabolic process (GO:0006084) | 3.31319110 |
| 135 | DNA double-strand break processing (GO:0000729) | 3.30770851 |
| 136 | mitotic spindle assembly checkpoint (GO:0007094) | 3.29653736 |
| 137 | glutamate metabolic process (GO:0006536) | 3.28970274 |
| 138 | regulation of helicase activity (GO:0051095) | 3.27073953 |
| 139 | tRNA aminoacylation for protein translation (GO:0006418) | 3.27059334 |
| 140 | glucuronate metabolic process (GO:0019585) | 3.26798928 |
| 141 | uronic acid metabolic process (GO:0006063) | 3.26798928 |
| 142 | fatty acid catabolic process (GO:0009062) | 3.26646188 |
| 143 | DNA replication initiation (GO:0006270) | 3.25160059 |
| 144 | spindle assembly checkpoint (GO:0071173) | 3.24910280 |
| 145 | drug metabolic process (GO:0017144) | 3.23749438 |
| 146 | monocarboxylic acid catabolic process (GO:0072329) | 3.23000416 |
| 147 | sister chromatid segregation (GO:0000819) | 3.22877869 |
| 148 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.22700411 |
| 149 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.22700411 |
| 150 | amino acid activation (GO:0043038) | 3.21287849 |
| 151 | tRNA aminoacylation (GO:0043039) | 3.21287849 |
| 152 | NAD biosynthetic process (GO:0009435) | 3.21033465 |
| 153 | synapsis (GO:0007129) | 3.19860221 |
| 154 | folic acid metabolic process (GO:0046655) | 3.18776228 |
| 155 | regulation of centriole replication (GO:0046599) | 3.18268312 |
| 156 | regulation of chromosome segregation (GO:0051983) | 3.18170761 |
| 157 | ketone body metabolic process (GO:1902224) | 3.18087058 |
| 158 | mitotic nuclear envelope disassembly (GO:0007077) | 3.17853261 |
| 159 | coenzyme catabolic process (GO:0009109) | 3.16968498 |
| 160 | arginine metabolic process (GO:0006525) | 3.16137237 |
| 161 | flavonoid metabolic process (GO:0009812) | 3.15869062 |
| 162 | regulation of bile acid biosynthetic process (GO:0070857) | 3.14625494 |
| 163 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.14070069 |
| 164 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.14070069 |
| 165 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.12108634 |
| 166 | sulfur amino acid metabolic process (GO:0000096) | 3.11591934 |
| 167 | regulation of sister chromatid segregation (GO:0033045) | 3.11294454 |
| 168 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.11294454 |
| 169 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.11294454 |
| 170 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.10401010 |
| 171 | telomere maintenance via telomere lengthening (GO:0010833) | 3.10303539 |
| 172 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.10161933 |
| 173 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.10161933 |
| 174 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.06556663 |
| 175 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.06136218 |
| 176 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.06136218 |
| 177 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.02375799 |
| 178 | mitochondrial RNA metabolic process (GO:0000959) | 3.02282665 |
| 179 | transcription from mitochondrial promoter (GO:0006390) | 2.98242350 |
| 180 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.98037657 |
| 181 | cell cycle G1/S phase transition (GO:0044843) | 2.98037657 |
| 182 | rRNA modification (GO:0000154) | 2.97182564 |
| 183 | mitotic G2/M transition checkpoint (GO:0044818) | 2.96091183 |
| 184 | mitotic chromosome condensation (GO:0007076) | 2.95691419 |
| 185 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.95121283 |
| 186 | isotype switching (GO:0045190) | 2.95121283 |
| 187 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.95121283 |
| 188 | ribosomal large subunit biogenesis (GO:0042273) | 2.92979424 |
| 189 | cullin deneddylation (GO:0010388) | 2.91210001 |
| 190 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.91120024 |
| 191 | nuclear envelope disassembly (GO:0051081) | 2.88913589 |
| 192 | membrane disassembly (GO:0030397) | 2.88913589 |
| 193 | ribosome biogenesis (GO:0042254) | 2.87793541 |
| 194 | kinetochore organization (GO:0051383) | 2.85071217 |
| 195 | response to X-ray (GO:0010165) | 2.85038186 |
| 196 | histone mRNA metabolic process (GO:0008334) | 2.84820636 |
| 197 | ATP-dependent chromatin remodeling (GO:0043044) | 2.83111946 |
| 198 | establishment of chromosome localization (GO:0051303) | 2.82923251 |
| 199 | protein complex localization (GO:0031503) | 2.82375716 |
| 200 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.82116145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.93632422 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.57158571 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.18087253 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.04073016 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.13035848 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.09831378 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.87282142 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.79538645 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.55517266 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.02807023 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.47847781 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.34047961 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.21997778 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.20272116 |
| 15 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.18753085 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15151223 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08793725 |
| 18 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.00392620 |
| 19 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.98881866 |
| 20 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.89325195 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.86679760 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.85969341 |
| 23 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78376258 |
| 24 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.77695422 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74679440 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.73181867 |
| 27 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.72500575 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.72242808 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68943116 |
| 30 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.62284496 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.59771597 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55759442 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.51044556 |
| 34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.48072814 |
| 35 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.45220249 |
| 36 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.44840855 |
| 37 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42694468 |
| 38 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40526746 |
| 39 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.39789073 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.38830133 |
| 41 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.37365041 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35957772 |
| 43 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.35104294 |
| 44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.31780179 |
| 45 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.31396509 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30191780 |
| 47 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.28438747 |
| 48 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.27485644 |
| 49 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.24196742 |
| 50 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.22629686 |
| 51 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.21274249 |
| 52 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20121311 |
| 53 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18972870 |
| 54 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18825103 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15032437 |
| 56 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.14426617 |
| 57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.12735061 |
| 58 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12469892 |
| 59 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.11616163 |
| 60 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.11119345 |
| 61 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10469088 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10245032 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10232352 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.10230253 |
| 65 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.09633792 |
| 66 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08876715 |
| 67 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07763099 |
| 68 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.05369877 |
| 69 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02373547 |
| 70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01934823 |
| 71 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.01360490 |
| 72 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.01202564 |
| 73 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00843814 |
| 74 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00138451 |
| 75 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97295529 |
| 76 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.96703153 |
| 77 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95740195 |
| 78 | FUS_26573619_Chip-Seq_HEK293_Human | 0.95082016 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93895146 |
| 80 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.93888059 |
| 81 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.92897660 |
| 82 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.92121222 |
| 83 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.91785675 |
| 84 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.91737661 |
| 85 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91274825 |
| 86 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90340726 |
| 87 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.89345486 |
| 88 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.89125560 |
| 89 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.89123346 |
| 90 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.88710092 |
| 91 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.87054840 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.84674732 |
| 93 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.84547874 |
| 94 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.84533268 |
| 95 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.83789656 |
| 96 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83680673 |
| 97 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83338551 |
| 98 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82855012 |
| 99 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.80615943 |
| 100 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.79756782 |
| 101 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.79424714 |
| 102 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.79387270 |
| 103 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.79258733 |
| 104 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77989277 |
| 105 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.77622281 |
| 106 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.77575409 |
| 107 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77350574 |
| 108 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.77018875 |
| 109 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.76466959 |
| 110 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.75491798 |
| 111 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.75450367 |
| 112 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.75413919 |
| 113 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.74346289 |
| 114 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.74301368 |
| 115 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.73849496 |
| 116 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72817509 |
| 117 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72772064 |
| 118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72589181 |
| 119 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.72339522 |
| 120 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.70784005 |
| 121 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70716256 |
| 122 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.70714903 |
| 123 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.69894835 |
| 124 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.68870360 |
| 125 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.68550799 |
| 126 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68404921 |
| 127 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.67676665 |
| 128 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.67381877 |
| 129 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.67286612 |
| 130 | AR_20517297_ChIP-Seq_VCAP_Human | 0.67259739 |
| 131 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.67147406 |
| 132 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.66322669 |
| 133 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.65944081 |
| 134 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65708532 |
| 135 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.64872585 |
| 136 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.64385051 |
| 137 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64250268 |
| 138 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.63049472 |
| 139 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.62829486 |
| 140 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.62639630 |
| 141 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62135297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.14542133 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.93484813 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.18616188 |
| 4 | MP0005365_abnormal_bile_salt | 5.11936055 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.23407976 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.17405576 |
| 7 | MP0003252_abnormal_bile_duct | 3.28250301 |
| 8 | MP0003941_abnormal_skin_development | 3.22317832 |
| 9 | MP0008932_abnormal_embryonic_tissue | 2.97246728 |
| 10 | MP0005332_abnormal_amino_acid | 2.91038450 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.85101390 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.72482526 |
| 13 | MP0003195_calcinosis | 2.53531216 |
| 14 | MP0009840_abnormal_foam_cell | 2.53022349 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.44411166 |
| 16 | MP0008877_abnormal_DNA_methylation | 2.42508225 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.40292126 |
| 18 | MP0001730_embryonic_growth_arrest | 2.26871797 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.25446723 |
| 20 | MP0003890_abnormal_embryonic-extraembry | 2.15072791 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.02127190 |
| 22 | MP0001764_abnormal_homeostasis | 1.97506370 |
| 23 | MP0003186_abnormal_redox_activity | 1.96795704 |
| 24 | MP0005083_abnormal_biliary_tract | 1.96014781 |
| 25 | MP0000609_abnormal_liver_physiology | 1.91409906 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.82699392 |
| 27 | MP0003786_premature_aging | 1.79418972 |
| 28 | MP0000350_abnormal_cell_proliferation | 1.78892046 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.76041251 |
| 30 | MP0001697_abnormal_embryo_size | 1.72569334 |
| 31 | MP0003567_abnormal_fetal_cardiomyocyte | 1.71415517 |
| 32 | MP0005380_embryogenesis_phenotype | 1.69448751 |
| 33 | MP0001672_abnormal_embryogenesis/_devel | 1.69448751 |
| 34 | MP0009697_abnormal_copulation | 1.66006553 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.56378390 |
| 36 | MP0001293_anophthalmia | 1.52682580 |
| 37 | MP0003984_embryonic_growth_retardation | 1.51333340 |
| 38 | MP0005501_abnormal_skin_physiology | 1.48488270 |
| 39 | MP0002080_prenatal_lethality | 1.48331133 |
| 40 | MP0005451_abnormal_body_composition | 1.47775530 |
| 41 | MP0002088_abnormal_embryonic_growth/wei | 1.46289478 |
| 42 | MP0002084_abnormal_developmental_patter | 1.41182907 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 1.38011552 |
| 44 | MP0000358_abnormal_cell_content/ | 1.33954344 |
| 45 | MP0002009_preneoplasia | 1.30492812 |
| 46 | MP0000313_abnormal_cell_death | 1.30225607 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29491707 |
| 48 | MP0002086_abnormal_extraembryonic_tissu | 1.27570594 |
| 49 | MP0002085_abnormal_embryonic_tissue | 1.27561534 |
| 50 | MP0005636_abnormal_mineral_homeostasis | 1.24781932 |
| 51 | MP0004197_abnormal_fetal_growth/weight/ | 1.19487320 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.19217088 |
| 53 | MP0000598_abnormal_liver_morphology | 1.18081130 |
| 54 | MP0005084_abnormal_gallbladder_morpholo | 1.17586486 |
| 55 | MP0003868_abnormal_feces_composition | 1.16421264 |
| 56 | MP0001929_abnormal_gametogenesis | 1.13473779 |
| 57 | MP0000372_irregular_coat_pigmentation | 1.13379912 |
| 58 | MP0002210_abnormal_sex_determination | 1.11828777 |
| 59 | MP0009764_decreased_sensitivity_to | 1.11784754 |
| 60 | MP0003718_maternal_effect | 1.10330395 |
| 61 | MP0004264_abnormal_extraembryonic_tissu | 1.09043974 |
| 62 | MP0003937_abnormal_limbs/digits/tail_de | 1.07400275 |
| 63 | MP0003693_abnormal_embryo_hatching | 1.06756758 |
| 64 | MP0000490_abnormal_crypts_of | 1.06366771 |
| 65 | MP0008469_abnormal_protein_level | 1.05033516 |
| 66 | MP0005408_hypopigmentation | 1.03599731 |
| 67 | MP0001145_abnormal_male_reproductive | 1.03097152 |
| 68 | MP0004043_abnormal_pH_regulation | 1.01506641 |
| 69 | MP0001756_abnormal_urination | 1.00482494 |
| 70 | MP0006292_abnormal_olfactory_placode | 1.00045414 |
| 71 | MP0009763_increased_sensitivity_to | 0.99664683 |
| 72 | MP0010678_abnormal_skin_adnexa | 0.98383671 |
| 73 | MP0000647_abnormal_sebaceous_gland | 0.97174282 |
| 74 | MP0003724_increased_susceptibility_to | 0.95997540 |
| 75 | MP0003315_abnormal_perineum_morphology | 0.95722170 |
| 76 | MP0000653_abnormal_sex_gland | 0.95495701 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.94387623 |
| 78 | MP0005670_abnormal_white_adipose | 0.93696504 |
| 79 | MP0009703_decreased_birth_body | 0.92441858 |
| 80 | MP0000579_abnormal_nail_morphology | 0.92399693 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.92051382 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.89852115 |
| 83 | MP0005266_abnormal_metabolism | 0.87243346 |
| 84 | MP0005647_abnormal_sex_gland | 0.86661712 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 0.85893086 |
| 86 | MP0003705_abnormal_hypodermis_morpholog | 0.85519375 |
| 87 | MP0001661_extended_life_span | 0.84541398 |
| 88 | MP0001286_abnormal_eye_development | 0.84267143 |
| 89 | MP0006035_abnormal_mitochondrial_morpho | 0.83048746 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.81673233 |
| 91 | MP0002697_abnormal_eye_size | 0.81461156 |
| 92 | MP0004957_abnormal_blastocyst_morpholog | 0.81254933 |
| 93 | MP0009053_abnormal_anal_canal | 0.80974102 |
| 94 | MP0002111_abnormal_tail_morphology | 0.80962660 |
| 95 | MP0001881_abnormal_mammary_gland | 0.80820371 |
| 96 | MP0005220_abnormal_exocrine_pancreas | 0.80787002 |
| 97 | MP0009642_abnormal_blood_homeostasis | 0.80328366 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.78643488 |
| 99 | MP0002102_abnormal_ear_morphology | 0.78151508 |
| 100 | MP0001853_heart_inflammation | 0.78008521 |
| 101 | MP0001188_hyperpigmentation | 0.77865115 |
| 102 | MP0002938_white_spotting | 0.77524473 |
| 103 | MP0010094_abnormal_chromosome_stability | 0.77076087 |
| 104 | MP0002160_abnormal_reproductive_system | 0.76854562 |
| 105 | MP0000627_abnormal_mammary_gland | 0.73840791 |
| 106 | MP0008260_abnormal_autophagy | 0.73358029 |
| 107 | MP0005384_cellular_phenotype | 0.73095357 |
| 108 | MP0001216_abnormal_epidermal_layer | 0.72806304 |
| 109 | MP0003011_delayed_dark_adaptation | 0.72237382 |
| 110 | MP0004215_abnormal_myocardial_fiber | 0.71999976 |
| 111 | MP0005395_other_phenotype | 0.71910787 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.71278977 |
| 113 | MP0002006_tumorigenesis | 0.71127579 |
| 114 | MP0001727_abnormal_embryo_implantation | 0.70854233 |
| 115 | MP0002254_reproductive_system_inflammat | 0.70336858 |
| 116 | MP0009785_altered_susceptibility_to | 0.66834457 |
| 117 | MP0004147_increased_porphyrin_level | 0.66311926 |
| 118 | MP0003119_abnormal_digestive_system | 0.65113501 |
| 119 | MP0003436_decreased_susceptibility_to | 0.64899771 |
| 120 | MP0002132_abnormal_respiratory_system | 0.64566637 |
| 121 | MP0006072_abnormal_retinal_apoptosis | 0.64114533 |
| 122 | MP0002090_abnormal_vision | 0.63697402 |
| 123 | MP0008789_abnormal_olfactory_epithelium | 0.63186676 |
| 124 | MP0000377_abnormal_hair_follicle | 0.62996307 |
| 125 | MP0000537_abnormal_urethra_morphology | 0.62963442 |
| 126 | MP0000383_abnormal_hair_follicle | 0.62639312 |
| 127 | MP0003943_abnormal_hepatobiliary_system | 0.62380421 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.61766593 |
| 129 | MP0003698_abnormal_male_reproductive | 0.61337291 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.60242952 |
| 131 | MP0004233_abnormal_muscle_weight | 0.59402307 |
| 132 | MP0003111_abnormal_nucleus_morphology | 0.59400252 |
| 133 | MP0005464_abnormal_platelet_physiology | 0.59142828 |
| 134 | MP0004808_abnormal_hematopoietic_stem | 0.57826248 |
| 135 | MP0006054_spinal_hemorrhage | 0.56717987 |
| 136 | MP0002971_abnormal_brown_adipose | 0.56476745 |
| 137 | MP0002092_abnormal_eye_morphology | 0.56002901 |
| 138 | MP0001191_abnormal_skin_condition | 0.55368720 |
| 139 | MP0004185_abnormal_adipocyte_glucose | 0.55339180 |
| 140 | MP0002928_abnormal_bile_duct | 0.53498457 |
| 141 | MP0001835_abnormal_antigen_presentation | 0.52708300 |
| 142 | MP0010155_abnormal_intestine_physiology | 0.52306293 |
| 143 | MP0008058_abnormal_DNA_repair | 0.51307741 |
| 144 | MP0001765_abnormal_ion_homeostasis | 0.51181367 |
| 145 | MP0003077_abnormal_cell_cycle | 0.50222072 |
| 146 | MP0002396_abnormal_hematopoietic_system | 0.46601586 |
| 147 | MP0005666_abnormal_adipose_tissue | 0.46263304 |
| 148 | MP0003221_abnormal_cardiomyocyte_apopto | 0.46005702 |
| 149 | MP0010352_gastrointestinal_tract_polyps | 0.45189584 |
| 150 | MP0008873_increased_physiological_sensi | 0.44523408 |
| 151 | MP0002135_abnormal_kidney_morphology | 0.44398205 |
| 152 | MP0010234_abnormal_vibrissa_follicle | 0.44066915 |
| 153 | MP0005334_abnormal_fat_pad | 0.43942100 |
| 154 | MP0005025_abnormal_response_to | 0.42705913 |
| 155 | MP0003638_abnormal_response/metabolism_ | 0.42103843 |
| 156 | MP0009672_abnormal_birth_weight | 0.41591332 |
| 157 | MP0003646_muscle_fatigue | 0.41142800 |
| 158 | MP0008057_abnormal_DNA_replication | 0.40413497 |
| 159 | MP0005535_abnormal_body_temperature | 0.39817540 |
| 160 | MP0004130_abnormal_muscle_cell | 0.38362442 |
| 161 | MP0009115_abnormal_fat_cell | 0.38078160 |
| 162 | MP0002796_impaired_skin_barrier | 0.37923397 |
| 163 | MP0001119_abnormal_female_reproductive | 0.37331768 |
| 164 | MP0000689_abnormal_spleen_morphology | 0.37294112 |
| 165 | MP0010368_abnormal_lymphatic_system | 0.37177584 |
| 166 | MP0002166_altered_tumor_susceptibility | 0.37062975 |
| 167 | MP0002019_abnormal_tumor_incidence | 0.36097381 |
| 168 | MP0010307_abnormal_tumor_latency | 0.36058411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.70686941 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.68344514 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.34255985 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.09259314 |
| 5 | Hyperglycinuria (HP:0003108) | 4.91199881 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.69125897 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.60684452 |
| 8 | Xanthomatosis (HP:0000991) | 4.56889927 |
| 9 | Hyperglycinemia (HP:0002154) | 4.55175814 |
| 10 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.46451412 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.41490510 |
| 12 | Hyperammonemia (HP:0001987) | 4.40555748 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.39607530 |
| 14 | Abnormality of glycine metabolism (HP:0010895) | 4.39607530 |
| 15 | Chromsome breakage (HP:0040012) | 4.37706534 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15652130 |
| 17 | Hypoglycemic coma (HP:0001325) | 4.13281662 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.01756008 |
| 19 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.01309073 |
| 20 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91766241 |
| 21 | Ketosis (HP:0001946) | 3.89032910 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.76328363 |
| 23 | Gout (HP:0001997) | 3.71306782 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.69410718 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 3.63510494 |
| 26 | Fat malabsorption (HP:0002630) | 3.63468319 |
| 27 | Abnormality of nucleobase metabolism (HP:0010932) | 3.57945228 |
| 28 | Generalized aminoaciduria (HP:0002909) | 3.50290314 |
| 29 | Abnormality of chromosome stability (HP:0003220) | 3.47736881 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41633000 |
| 31 | Abnormality of purine metabolism (HP:0004352) | 3.41034722 |
| 32 | Complement deficiency (HP:0004431) | 3.41029341 |
| 33 | Proximal tubulopathy (HP:0000114) | 3.40935043 |
| 34 | Abnormality of serum amino acid levels (HP:0003112) | 3.40445368 |
| 35 | Joint hemorrhage (HP:0005261) | 3.39549462 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.35787741 |
| 37 | Dicarboxylic aciduria (HP:0003215) | 3.29795563 |
| 38 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.29795563 |
| 39 | Ketoacidosis (HP:0001993) | 3.22356077 |
| 40 | Epidermoid cyst (HP:0200040) | 3.22164305 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 3.20825024 |
| 42 | Meckel diverticulum (HP:0002245) | 3.20393855 |
| 43 | Colon cancer (HP:0003003) | 3.19512105 |
| 44 | Abnormality of the preputium (HP:0100587) | 3.17500962 |
| 45 | Conjugated hyperbilirubinemia (HP:0002908) | 3.12909422 |
| 46 | Hypoalphalipoproteinemia (HP:0003233) | 3.09033812 |
| 47 | Abnormality of glycolysis (HP:0004366) | 3.08273823 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 3.07155311 |
| 49 | Microvesicular hepatic steatosis (HP:0001414) | 3.05635203 |
| 50 | Increased serum pyruvate (HP:0003542) | 3.05628272 |
| 51 | Lethargy (HP:0001254) | 3.00440459 |
| 52 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.00375187 |
| 53 | Abnormality of the ileum (HP:0001549) | 3.00222339 |
| 54 | Metabolic acidosis (HP:0001942) | 2.99676490 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.97929016 |
| 56 | Rhabdomyosarcoma (HP:0002859) | 2.93690350 |
| 57 | Multiple enchondromatosis (HP:0005701) | 2.93286329 |
| 58 | Hyperbilirubinemia (HP:0002904) | 2.90935090 |
| 59 | Embryonal renal neoplasm (HP:0011794) | 2.86311682 |
| 60 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.82619312 |
| 61 | Birth length less than 3rd percentile (HP:0003561) | 2.81742765 |
| 62 | Steatorrhea (HP:0002570) | 2.80213256 |
| 63 | Increased purine levels (HP:0004368) | 2.80117196 |
| 64 | Hyperuricemia (HP:0002149) | 2.80117196 |
| 65 | Abnormal lung lobation (HP:0002101) | 2.78831295 |
| 66 | Small intestinal stenosis (HP:0012848) | 2.77664628 |
| 67 | Duodenal stenosis (HP:0100867) | 2.77664628 |
| 68 | Abnormality of the labia minora (HP:0012880) | 2.77432373 |
| 69 | Degeneration of anterior horn cells (HP:0002398) | 2.72309610 |
| 70 | Abnormality of the anterior horn cell (HP:0006802) | 2.72309610 |
| 71 | Glycosuria (HP:0003076) | 2.66420654 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.66420654 |
| 73 | Medulloblastoma (HP:0002885) | 2.66411989 |
| 74 | Cerebral edema (HP:0002181) | 2.65988343 |
| 75 | Nausea (HP:0002018) | 2.63390492 |
| 76 | Renal cortical cysts (HP:0000803) | 2.57721155 |
| 77 | Acute encephalopathy (HP:0006846) | 2.55618671 |
| 78 | Hypercholesterolemia (HP:0003124) | 2.55500404 |
| 79 | Reticulocytopenia (HP:0001896) | 2.51457987 |
| 80 | Type I transferrin isoform profile (HP:0003642) | 2.51366247 |
| 81 | Ependymoma (HP:0002888) | 2.51149688 |
| 82 | Cortical dysplasia (HP:0002539) | 2.47590538 |
| 83 | Myelodysplasia (HP:0002863) | 2.44758939 |
| 84 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.44724914 |
| 85 | Hepatocellular carcinoma (HP:0001402) | 2.43979894 |
| 86 | Abnormality of complement system (HP:0005339) | 2.43456519 |
| 87 | Acanthocytosis (HP:0001927) | 2.40940367 |
| 88 | Abnormality of the duodenum (HP:0002246) | 2.40829036 |
| 89 | Vascular calcification (HP:0004934) | 2.40085654 |
| 90 | Spastic diplegia (HP:0001264) | 2.39963343 |
| 91 | Neoplasm of the colon (HP:0100273) | 2.35846059 |
| 92 | Malnutrition (HP:0004395) | 2.27197658 |
| 93 | Abnormality of alanine metabolism (HP:0010916) | 2.26879062 |
| 94 | Hyperalaninemia (HP:0003348) | 2.26879062 |
| 95 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.26879062 |
| 96 | Ovarian neoplasm (HP:0100615) | 2.26073690 |
| 97 | Neoplasm of the adrenal gland (HP:0100631) | 2.25373234 |
| 98 | Vomiting (HP:0002013) | 2.25179867 |
| 99 | Biliary tract neoplasm (HP:0100574) | 2.24660925 |
| 100 | Volvulus (HP:0002580) | 2.24130450 |
| 101 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.23777259 |
| 102 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.23777259 |
| 103 | Abnormal protein glycosylation (HP:0012346) | 2.23777259 |
| 104 | Abnormal glycosylation (HP:0012345) | 2.23777259 |
| 105 | Acute necrotizing encephalopathy (HP:0006965) | 2.23561603 |
| 106 | Pancreatitis (HP:0001733) | 2.22513852 |
| 107 | Abnormality of proline metabolism (HP:0010907) | 2.22347303 |
| 108 | Hydroxyprolinuria (HP:0003080) | 2.22347303 |
| 109 | Hypoglycemic seizures (HP:0002173) | 2.20837724 |
| 110 | Alkalosis (HP:0001948) | 2.17726647 |
| 111 | Stenosis of the external auditory canal (HP:0000402) | 2.15482901 |
| 112 | Gonadotropin excess (HP:0000837) | 2.13252215 |
| 113 | Breast carcinoma (HP:0003002) | 2.11258918 |
| 114 | Irritability (HP:0000737) | 2.10761440 |
| 115 | Increased hepatocellular lipid droplets (HP:0006565) | 2.10229948 |
| 116 | Acute hepatic failure (HP:0006554) | 2.09650540 |
| 117 | Cardiovascular calcification (HP:0011915) | 2.07052526 |
| 118 | Agnosia (HP:0010524) | 2.06589491 |
| 119 | Increased serum lactate (HP:0002151) | 2.06006454 |
| 120 | Enlarged kidneys (HP:0000105) | 2.05658386 |
| 121 | Systemic lupus erythematosus (HP:0002725) | 2.04406995 |
| 122 | Hepatic necrosis (HP:0002605) | 2.04033851 |
| 123 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.02457948 |
| 124 | Sloping forehead (HP:0000340) | 1.98949585 |
| 125 | Increased CSF lactate (HP:0002490) | 1.98932758 |
| 126 | Increased nuchal translucency (HP:0010880) | 1.98898627 |
| 127 | Aplastic anemia (HP:0001915) | 1.98701222 |
| 128 | Spontaneous abortion (HP:0005268) | 1.97908164 |
| 129 | Elevated hepatic transaminases (HP:0002910) | 1.97878601 |
| 130 | Horseshoe kidney (HP:0000085) | 1.97821980 |
| 131 | Progressive external ophthalmoplegia (HP:0000590) | 1.97281482 |
| 132 | Glioma (HP:0009733) | 1.97018686 |
| 133 | Postnatal microcephaly (HP:0005484) | 1.96980612 |
| 134 | Uterine neoplasm (HP:0010784) | 1.96197276 |
| 135 | IgM deficiency (HP:0002850) | 1.96023282 |
| 136 | Reduced antithrombin III activity (HP:0001976) | 1.95214093 |
| 137 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94223323 |
| 138 | Absent radius (HP:0003974) | 1.94215564 |
| 139 | Late onset (HP:0003584) | 1.93673168 |
| 140 | Palpitations (HP:0001962) | 1.92422861 |
| 141 | Neoplasm of the small intestine (HP:0100833) | 1.92321440 |
| 142 | Sensorimotor neuropathy (HP:0007141) | 1.92194155 |
| 143 | Myocardial infarction (HP:0001658) | 1.91506235 |
| 144 | Lipid accumulation in hepatocytes (HP:0006561) | 1.90550880 |
| 145 | Megaloblastic anemia (HP:0001889) | 1.89602134 |
| 146 | Opisthotonus (HP:0002179) | 1.89226021 |
| 147 | Esophageal varix (HP:0002040) | 1.88406788 |
| 148 | Lactic acidosis (HP:0003128) | 1.86231300 |
| 149 | Clubbing of toes (HP:0100760) | 1.85595796 |
| 150 | Sparse eyelashes (HP:0000653) | 1.85171863 |
| 151 | Thrombophlebitis (HP:0004418) | 1.83799048 |
| 152 | Neoplasm of the rectum (HP:0100743) | 1.83545344 |
| 153 | Hyperglycemia (HP:0003074) | 1.83304990 |
| 154 | Macrocytic anemia (HP:0001972) | 1.82712865 |
| 155 | Angiofibromas (HP:0010615) | 1.82213499 |
| 156 | Adenoma sebaceum (HP:0009720) | 1.82213499 |
| 157 | Abnormal cartilage morphology (HP:0002763) | 1.82171348 |
| 158 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80521727 |
| 159 | Dyschromatopsia (HP:0007641) | 1.80487311 |
| 160 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80085311 |
| 161 | Exercise-induced muscle cramps (HP:0003710) | 1.79452982 |
| 162 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78125012 |
| 163 | Skin nodule (HP:0200036) | 1.77181272 |
| 164 | Neonatal onset (HP:0003623) | 1.76986916 |
| 165 | Hypochromic microcytic anemia (HP:0004840) | 1.76769843 |
| 166 | Selective tooth agenesis (HP:0001592) | 1.76274797 |
| 167 | Carpal bone hypoplasia (HP:0001498) | 1.76218318 |
| 168 | Pancytopenia (HP:0001876) | 1.76117199 |
| 169 | Progressive macrocephaly (HP:0004481) | 1.76036632 |
| 170 | Rhabdomyolysis (HP:0003201) | 1.76013140 |
| 171 | Aplasia involving forearm bones (HP:0009822) | 1.75513003 |
| 172 | Absent forearm bone (HP:0003953) | 1.75513003 |
| 173 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75217645 |
| 174 | Thyroid carcinoma (HP:0002890) | 1.74292195 |
| 175 | Symptomatic seizures (HP:0011145) | 1.74203866 |
| 176 | Abnormality of homocysteine metabolism (HP:0010919) | 1.74037256 |
| 177 | Homocystinuria (HP:0002156) | 1.74037256 |
| 178 | Abnormality of vitamin metabolism (HP:0100508) | 1.73773258 |
| 179 | Choanal atresia (HP:0000453) | 1.73333663 |
| 180 | Triphalangeal thumb (HP:0001199) | 1.73182760 |
| 181 | Brushfield spots (HP:0001088) | 1.72136187 |
| 182 | Posterior subcapsular cataract (HP:0007787) | 1.69844335 |
| 183 | Proximal placement of thumb (HP:0009623) | 1.69283407 |
| 184 | Methylmalonic aciduria (HP:0012120) | 1.68245823 |
| 185 | Abnormality of iron homeostasis (HP:0011031) | 1.67753498 |
| 186 | Rickets (HP:0002748) | 1.67598633 |
| 187 | Poikilocytosis (HP:0004447) | 1.66587166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.18158568 |
| 2 | PBK | 3.44175898 |
| 3 | FRK | 2.41350080 |
| 4 | TRIM28 | 2.39262965 |
| 5 | FGFR4 | 2.29180354 |
| 6 | STK16 | 2.26017442 |
| 7 | MKNK1 | 2.23213392 |
| 8 | PLK3 | 2.20316299 |
| 9 | NEK1 | 2.15813222 |
| 10 | INSRR | 2.14136138 |
| 11 | EIF2AK1 | 2.13901695 |
| 12 | ACVR1B | 2.11297482 |
| 13 | FLT3 | 2.10456166 |
| 14 | ERN1 | 2.10443643 |
| 15 | VRK2 | 2.06583458 |
| 16 | TAF1 | 2.00136064 |
| 17 | STK38L | 1.93899321 |
| 18 | WEE1 | 1.93023720 |
| 19 | MKNK2 | 1.87950044 |
| 20 | PDK4 | 1.69300039 |
| 21 | PDK3 | 1.69300039 |
| 22 | NEK9 | 1.69053170 |
| 23 | EIF2AK3 | 1.67342586 |
| 24 | BRSK2 | 1.67272482 |
| 25 | TYK2 | 1.65385741 |
| 26 | MAP3K14 | 1.61028607 |
| 27 | KDR | 1.59085789 |
| 28 | BCR | 1.57119536 |
| 29 | SCYL2 | 1.55485548 |
| 30 | WNK3 | 1.53372165 |
| 31 | BUB1 | 1.52819604 |
| 32 | NME2 | 1.49471449 |
| 33 | MAP2K3 | 1.45766391 |
| 34 | MAP3K3 | 1.43257758 |
| 35 | ERBB4 | 1.42955671 |
| 36 | LATS1 | 1.42744218 |
| 37 | PDK2 | 1.42575427 |
| 38 | PIK3CG | 1.39179846 |
| 39 | MAPK11 | 1.36527955 |
| 40 | SIK1 | 1.29759723 |
| 41 | EPHA2 | 1.26880769 |
| 42 | ERBB3 | 1.26570626 |
| 43 | IRAK3 | 1.25658335 |
| 44 | ZAK | 1.23353409 |
| 45 | TTK | 1.14356178 |
| 46 | TAOK3 | 1.12366883 |
| 47 | PKN2 | 1.12277634 |
| 48 | MST1R | 1.09615912 |
| 49 | RPS6KA4 | 1.09348712 |
| 50 | NME1 | 1.09019124 |
| 51 | CDK4 | 1.08906330 |
| 52 | PLK4 | 1.07963200 |
| 53 | CHEK2 | 1.04522421 |
| 54 | PAK4 | 1.02554616 |
| 55 | BMPR1B | 0.99175126 |
| 56 | MST4 | 0.98571606 |
| 57 | AKT3 | 0.98076410 |
| 58 | SRPK1 | 0.97803317 |
| 59 | MAP3K12 | 0.97483373 |
| 60 | EIF2AK2 | 0.94709093 |
| 61 | BRSK1 | 0.91450536 |
| 62 | CDK19 | 0.90065427 |
| 63 | NEK2 | 0.88533972 |
| 64 | PINK1 | 0.87781893 |
| 65 | STK10 | 0.87224930 |
| 66 | MAP4K1 | 0.85535598 |
| 67 | AURKB | 0.85174849 |
| 68 | TBK1 | 0.83883904 |
| 69 | DYRK3 | 0.82321789 |
| 70 | CDK6 | 0.81734205 |
| 71 | ABL2 | 0.80387902 |
| 72 | TEC | 0.80060980 |
| 73 | STK3 | 0.80029005 |
| 74 | PLK1 | 0.79430321 |
| 75 | TXK | 0.78524178 |
| 76 | CHEK1 | 0.77436835 |
| 77 | TAOK2 | 0.77157414 |
| 78 | PIM1 | 0.76188745 |
| 79 | ATM | 0.75386872 |
| 80 | MAP2K6 | 0.74668532 |
| 81 | IRAK4 | 0.74238172 |
| 82 | JAK3 | 0.74095158 |
| 83 | PRKAA2 | 0.73927500 |
| 84 | CCNB1 | 0.73762364 |
| 85 | TSSK6 | 0.73091672 |
| 86 | ALK | 0.73052379 |
| 87 | OBSCN | 0.71047669 |
| 88 | NUAK1 | 0.70135308 |
| 89 | TGFBR1 | 0.69142517 |
| 90 | TIE1 | 0.68204890 |
| 91 | CDC7 | 0.67585904 |
| 92 | PNCK | 0.67263147 |
| 93 | CSNK1G1 | 0.66151528 |
| 94 | PLK2 | 0.64432425 |
| 95 | STK24 | 0.64124023 |
| 96 | CDK8 | 0.63632351 |
| 97 | IKBKE | 0.62969377 |
| 98 | STK4 | 0.62661062 |
| 99 | JAK1 | 0.62538645 |
| 100 | GRK6 | 0.61449630 |
| 101 | MET | 0.61332789 |
| 102 | GRK1 | 0.60943517 |
| 103 | TGFBR2 | 0.60082612 |
| 104 | MAP3K8 | 0.59756923 |
| 105 | ZAP70 | 0.59664877 |
| 106 | CHUK | 0.59525328 |
| 107 | FGFR1 | 0.59391319 |
| 108 | MAP3K11 | 0.58867170 |
| 109 | MAP3K5 | 0.58804005 |
| 110 | CDK7 | 0.58476587 |
| 111 | CSNK1G3 | 0.58343953 |
| 112 | PASK | 0.58241695 |
| 113 | DAPK1 | 0.57721738 |
| 114 | STK39 | 0.55669040 |
| 115 | TNIK | 0.55444397 |
| 116 | MYLK | 0.55299082 |
| 117 | ITK | 0.54638680 |
| 118 | RPS6KB2 | 0.53846635 |
| 119 | NLK | 0.53811458 |
| 120 | CSNK2A2 | 0.53706524 |
| 121 | AURKA | 0.52696668 |
| 122 | WNK4 | 0.51682397 |
| 123 | ATR | 0.50518546 |
| 124 | BLK | 0.50149592 |
| 125 | PTK6 | 0.49658591 |
| 126 | MAPKAPK3 | 0.49633210 |
| 127 | JAK2 | 0.48977524 |
| 128 | PRKAA1 | 0.48871454 |
| 129 | CSNK1A1L | 0.46984250 |
| 130 | IKBKB | 0.46339162 |
| 131 | VRK1 | 0.46022573 |
| 132 | YES1 | 0.45598393 |
| 133 | CSNK2A1 | 0.44353345 |
| 134 | BTK | 0.41955289 |
| 135 | CLK1 | 0.41758128 |
| 136 | MELK | 0.41677250 |
| 137 | CSNK1G2 | 0.40608396 |
| 138 | OXSR1 | 0.40399116 |
| 139 | CDK1 | 0.38973936 |
| 140 | BMPR2 | 0.38856794 |
| 141 | SIK3 | 0.35754042 |
| 142 | CSNK1E | 0.34195529 |
| 143 | CDK3 | 0.33657421 |
| 144 | CDK2 | 0.32253667 |
| 145 | CDK9 | 0.31945320 |
| 146 | MAP4K2 | 0.30304330 |
| 147 | FER | 0.29522580 |
| 148 | MAP3K10 | 0.28547134 |
| 149 | MATK | 0.27850089 |
| 150 | EGFR | 0.22764845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.44200069 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.11242516 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.84338898 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.79816433 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.53131205 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52852132 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52771592 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41536791 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40705707 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40429580 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.26155687 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.17310963 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.16739351 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.14729500 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 2.12945923 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05559001 |
| 17 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.93446804 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.91461682 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.90035583 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.89713754 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.89706421 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.88322699 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86963619 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.80585865 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.78921521 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77231735 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68742282 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.64073986 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.63226875 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62648429 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61893932 |
| 32 | Basal transcription factors_Homo sapiens_hsa03022 | 1.61664393 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59675596 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.58684154 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54888876 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.54612978 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.54352082 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53803526 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51785411 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.50053219 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.47675098 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.46911886 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.46542810 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41167387 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40653508 |
| 46 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.38738961 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37550013 |
| 48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.35607283 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35206766 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35177529 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30502468 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 1.22101780 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.18642998 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16240634 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15560520 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14795880 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13587193 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.12083634 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09694485 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07990064 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 1.06828711 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05469872 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02936440 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02356738 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99406768 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94189288 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.90661010 |
| 68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.89590499 |
| 69 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.89363594 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86893892 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83893203 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80851135 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79101101 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.78124971 |
| 75 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76422666 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71805582 |
| 77 | DNA replication_Homo sapiens_hsa03030 | 0.68107803 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66942140 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66052398 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62415932 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61914561 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58601237 |
| 83 | Proteasome_Homo sapiens_hsa03050 | 0.57879218 |
| 84 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57005152 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56015149 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54765618 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54144898 |
| 88 | Mismatch repair_Homo sapiens_hsa03430 | 0.51513623 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51307793 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51047242 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.49807087 |
| 92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46917832 |
| 93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.44934032 |
| 94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39260813 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37537353 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35110274 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30512149 |
| 98 | Base excision repair_Homo sapiens_hsa03410 | 0.27886998 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27729143 |
| 100 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.25134104 |
| 101 | Homologous recombination_Homo sapiens_hsa03440 | 0.24931691 |
| 102 | Adherens junction_Homo sapiens_hsa04520 | 0.24318593 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.21171744 |
| 104 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.20039944 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19133449 |
| 106 | RNA polymerase_Homo sapiens_hsa03020 | 0.18961709 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.18661168 |
| 108 | Legionellosis_Homo sapiens_hsa05134 | 0.16171372 |
| 109 | Purine metabolism_Homo sapiens_hsa00230 | 0.15914570 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15756769 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.13668769 |
| 112 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.13535302 |
| 113 | RNA transport_Homo sapiens_hsa03013 | 0.13139847 |
| 114 | Alcoholism_Homo sapiens_hsa05034 | 0.12029025 |
| 115 | Protein export_Homo sapiens_hsa03060 | 0.11971034 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.11654680 |
| 117 | Other glycan degradation_Homo sapiens_hsa00511 | 0.10843478 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.09726041 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.08487528 |
| 120 | RNA degradation_Homo sapiens_hsa03018 | 0.07152088 |
| 121 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.07061278 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06980961 |
| 123 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.06079035 |
| 124 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.05724655 |
| 125 | Cell cycle_Homo sapiens_hsa04110 | 0.04842796 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.04542282 |

